197 related articles for article (PubMed ID: 32852729)
1. Decreased serum myonectin concentrations in diabetic nephropathy patients.
Zhang J; Hu W; Lin P; Wang R
Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum Adropin Concentrations with Diabetic Nephropathy.
Hu W; Chen L
Mediators Inflamm; 2016; 2016():6038261. PubMed ID: 27546995
[TBL] [Abstract][Full Text] [Related]
3. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
4. Correlation of serum meteorin-like concentrations with diabetic nephropathy.
Wang R; Hu D; Zhao X; Hu W
Diabetes Res Clin Pract; 2020 Nov; 169():108443. PubMed ID: 32946852
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum preptin concentrations in patients with diabetic nephropathy.
Wang R; Xue A; Zheng W; Wang L; Yan F; Hu W; Lin J; He L
J Investig Med; 2019 Oct; 67(7):1048-1052. PubMed ID: 31182468
[TBL] [Abstract][Full Text] [Related]
6. Association of serum and aqueous humor myonectin concentrations with diabetic retinopathy.
Sun H; Li Z; Hu W; Ma W
Sci Rep; 2021 Mar; 11(1):7215. PubMed ID: 33785845
[TBL] [Abstract][Full Text] [Related]
7. The correlation of serum musclin with diabetic nephropathy.
Zhang J; Shi J; Cheng Z; Hu W
Cytokine; 2023 Jul; 167():156211. PubMed ID: 37137178
[TBL] [Abstract][Full Text] [Related]
8. Circulating Serum Myonectin Levels in Obesity and Type 2 Diabetes Mellitus.
Li Z; Yang YL; Zhu YJ; Li CG; Tang YZ; Ni CL; Chen LM; Niu WY
Exp Clin Endocrinol Diabetes; 2021 Jul; 129(7):528-534. PubMed ID: 31340393
[TBL] [Abstract][Full Text] [Related]
9. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
[TBL] [Abstract][Full Text] [Related]
10. Association of serum pentraxin 3 concentrations with diabetic nephropathy.
Wang R; Zhang J; Hu W
J Investig Med; 2016 Aug; 64(6):1124-7. PubMed ID: 27233528
[TBL] [Abstract][Full Text] [Related]
11. Correlation of serum myonectin concentrations with the presence and severity of obstructive sleep apnoea syndrome.
Zou H; Yang W; Liu Y
Ann Clin Biochem; 2021 Mar; 58(2):117-122. PubMed ID: 33231092
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients.
Chang YH; Lin KD; Wang CL; Hsieh MC; Hsiao PJ; Shin SJ
Diabetes Metab Res Rev; 2008; 24(8):629-34. PubMed ID: 18973209
[TBL] [Abstract][Full Text] [Related]
13. Reduced serum CTRP12 levels in type 2 diabetes are associated with renal dysfunction.
Du J; Xu J; Wang X; Liu Y; Zhao X; Zhang H
Int Urol Nephrol; 2020 Dec; 52(12):2321-2327. PubMed ID: 32734505
[TBL] [Abstract][Full Text] [Related]
14. Endocan and albuminuria in type 2 diabetes mellitus.
Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
[TBL] [Abstract][Full Text] [Related]
15. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
[TBL] [Abstract][Full Text] [Related]
16. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
17. Myonectin Predicts the Development of Type 2 Diabetes.
Li K; Liao X; Wang K; Mi Q; Zhang T; Jia Y; Xu X; Luo X; Zhang C; Liu H; Zhen H; Li L; Yang G
J Clin Endocrinol Metab; 2018 Jan; 103(1):139-147. PubMed ID: 29161407
[TBL] [Abstract][Full Text] [Related]
18. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
[TBL] [Abstract][Full Text] [Related]
19. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
20. Serum CXCL16 as a novel marker of renal injury in type 2 diabetes mellitus.
Zhao L; Wu F; Jin L; Lu T; Yang L; Pan X; Shao C; Li X; Lin Z
PLoS One; 2014; 9(1):e87786. PubMed ID: 24489966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
